Dana Rubin-Remer
Adolescent Medicine · Dallas, TXNPI 1174632053
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 191 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 18.2% — the pattern of someone who eats at a lot of different presentations.
Across 191 payments — averaging $19.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corium, LLC$683
- Tris Pharma Inc$531
- Ironshore Pharmaceuticals Inc.$471
- Supernus Pharmaceuticals, Inc.$404
- Noven Therapeutics, LLC$279
- Neos Therapeutics, LP$236
- plus $1K from 21 others
What the payments were for
- Food & beverage$3,753100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Corium, LLC | 28 | $683 |
| Tris Pharma Inc | 26 | $531 |
| Ironshore Pharmaceuticals Inc. | 26 | $471 |
| Supernus Pharmaceuticals, Inc. | 19 | $404 |
| Noven Therapeutics, LLC | 16 | $279 |
| Neos Therapeutics, LP | 12 | $236 |
| Collegium Pharmaceutical, Inc. | 14 | $202 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $174 |
| Exeltis, USA Inc. | 5 | $89 |
| Mayne Pharma Commercial LLC | 2 | $69 |
| Viiv Healthcare Company | 2 | $61 |
| Arbor Pharmaceuticals, Inc. | 4 | $54 |
| Vertical Pharmaceuticals, LLC | 3 | $52 |
| GSK | 3 | $50 |
| Shire North American Group Inc | 3 | $47 |
| Organon | 2 | $46 |
| Merck | 3 | $42 |
| Aytu Biopharma, Inc. | 3 | $42 |
| Millicent US Inc | 2 | $41 |
| Adlon Therapeutics L.p. | 2 | $40 |
| Alfasigma USA, Inc. | 2 | $38 |
| Mylan Pharmaceuticals Inc. | 1 | $23 |
| Galderma Laboratories, L.p. | 1 | $19 |
| Minerva Surgical, Inc | 1 | $17 |
| AstraZeneca | 1 | $17 |
| LNHC, Inc | 1 | $15 |
| Lilly USA, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Dyanavel XR$122
How this compares
$3,753 in reported general payments places this provider in the 85th percentile of 68 adolescent medicine providers in Texas.
Other adolescent medicine in Dallas
- Amy HayesDallas$2K
- M Brett CooperDallas$673
- Tariq MirzaDallas$448
- Daniel NaleDallas$375
- Neil LevyDallas$35
- Joan PurcellThe Woodlands$87K
- Amy MiddlemanHouston$70K
- Augustine ElejeEl Paso$37K
- Richard RuppGalveston$20K
- Scott SpearEdinburg$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.